Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif MajeurJennifer Swainson, Alexander McGirr, Pierre Blier, et al.
Translational Psychiatry|September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 studyFarhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
Translational Psychiatry|February 16, 2021
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant responseVictoria S Marshe, Malgorzata Maciukiewicz, Anne-Christin Hauschild, et al.
Bipolar Disorders|October 2, 2021
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentationsLakshmi N Yatham, Trisha Chakrabarty, David J Bond, et al.
Bipolar Disorders|March 15, 2018
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorderLakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.
The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.
Frontiers in Psychiatry|February 24, 2022
Common Data Elements to Facilitate Sharing and Re-use of Participant-Level Data: Assessment of Psychiatric Comorbidity Across Brain DisordersAnthony L Vaccarino, Derek Beaton, Sandra E Black, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 12, 2025
Canadian Network for Mood and Anxiety Treatments 2024 Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety, and Related Disorders: Guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatalsSimone N Vigod, Benicio N Frey, Crystal T Clark, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 7, 2024
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultesRaymond W Lam, Sidney H Kennedy, Camelia Adams, et al.
Pageof 5